Abstract
Rotavirus is the leading cause of gastroenteritis in children living in the UK ( Public Health England (PHE), 2013 ). On 1 July 2013, a live oral rotavirus vaccine, Rotarix (made by GlaxoSmithKline), was introduced into the national routine childhood immunization schedule for all children born on or after 1 May 2013. The programme is expected to reduce the incidence of rotavirus gastroenteritis in young children. This article provides a background to the introduction of the new vaccination programme, discussing the epidemiology and clinical features of rotavirus infection. As a major influence on vaccine uptake is the way in which health professionals communicate with parents and carers, this article highlights key vaccine and programme information for practitioners who promote and advise parents and carers about immunizations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
